SlideShare una empresa de Scribd logo
1 de 22
1
Department of Pharmacoinformatics
Mohd Rihan PI/309
NIPER HAJIPUR
Consensus Superiority of the Pharmacophore-Based Alignment, Over
Maximum Common Substructure (MCS): 3D-QSAR Studies on
Carbamates as Acetylcholinesterase Inhibitors
 Introduction
 Biological Data
 Rational Division of Trainning and Set Test
 Modeling Tools
 CoMFA and CoMSIAAnalysis
 CoMFA and CoMSIA Predictive Power
 Conclusion
 Alzheimer’s disease (AD) is A progressive irreversible disorder of elderly patients
which is characterized by widespread central cholinergic neuronal loss.
 The cholinesterase (ChE) inhibitors are being used to for the symptomatic
treatment of the ad affected persons.
 The AChE inhibitors are beneficial in improving cognitive and behavioral
symptoms, but their effectiveness has been questioned because they do not delay or
prevent the neurodegeneration.
 Newer approaches viz.
 Multitarget directed ligands (MTDLS) .
 Beta-amyloid targeted therapies(BATT).
 Two types of ChE enzyme
 Acetylcholinesterase
 Butyrylcholinesterase
 Computer aided drug design (CADD) techniques most commonly used techniques:
 Indirect/ligand based drug design (LBDD) .
 Direct/structure-based drug design (SBDD).
 Most commonly used conformer-based alignments, namely,
 Cocrystallized conformer-based alignment (CCBA).
 Docked conformer-based alignment (DCBA).
 Global minima energy conformer-based alignment (GMCBA).
 Complete X-ray structure of carbamates cocrystallized with AChE enzyme is not
available.
 Cocrystallized rivastigmine as well as ganstigmine are in broken form with
carbamate part being covalently bound with the OH functionality of the Ser200
amino acid residue.
 3D-QSAR model development using
 Comparative molecular field analysis (COMFA)
 Comparative molecular similarity indices analysis (COMSIA).
 Biological Data.
 3D-QSAR studies were performed on a structurally diverse set of 52 carbamates
covering a good range of AChE inhibitory activity.
 The pharmacophore modeling using the Hip-Hop algorithm implemented in the
CATALYST software carried out on 12 set of molecules with low to high activity.
 The AChE inhibitory activity of the compounds, expressed in the IC50 value in the
nanomolar (nM) range, was transformed into -logIC50 (pIC50).
 Several methods for the classification of the data set into training and test sets viz.
 Random sampling (RS),
 Activity ranked clustering (ARC)
 Descriptor based clustering (DBC
 Therefore, the data set comprising 52 compounds was divided into
 Training (35 compounds)
 Test (17 compounds) sets)
 The pharmacophore modeling was accomplished using the Hip-Hop module
implemented in CATALYST.
 The 3D-QSAR studies were done on a (CoMFA and CoMSIA) Silicon Graphics
Octane workstation using SYBYL 6.9 software.31.
Methodology.
 The steps used in the development of the 3D-QSAR model using the two strategies
viz.
 Hip-Hop algorithm based Alignment
 MCS-based Alignment
Maximum Common Substructure (MCS) of 52 AChE inhibitors
Hip-Hop algorithm-based conformational alignment of 52 AChE inhibitors
with the important regions assigned namely as Regions 1, 2, and 3.
(A) Common feature-based (Catalyst/Hip-Hop) pharmacophore model (Hypo1) with distance
angular Å.
(B) mapping of the most active molecule [Hydrophobic (blue), hydrogen bond acceptor
(green), ring aromatic (yellow), and positive ionizable (red) and the distance between
chemical features are shown in Å].
 Chemical features selection as input, CATALYST produces a series of possible
molecular alignments.
 CATALYST identify common features without considering biological activity.
 CATALYST produced possible molecular alignment and identify 3D configuration
features which is common in set of molecules.
 The hypotheses are ranked based on
 The number of molecules fitting the pharmacophore.
 The frequency of its occurrence (rank score).
* An idicates the test set compounds. An #indicates compounds used for pharmacophore design using the CATALYST/Hip-Hop module.
 CoMFA provided quantitative correlation of particular activity of molecules with
parameters in terms
 Steric
 Electrostatic field.
 In CoMFA analysis lignad paced in a 3D lattice and then steric and electrostatic
field of lattice can calculated.
 Resulting field of ligand is analysed by Patial Least Square (PLS).
 Procedure can be summarized into three steps:
 First, all molecules under study are aligned using a molecular alignment
methods Viz. common-substructure based, and pharmacophore-based, etc.
 3D cubic lattice with a grid spacing of 2.0 Å in x, y, and z directions are
generated to enclose the molecule aggregate.
 A probe atom, is placed at every lattice point to measure the electrostatic
(Columbic with 1/r dielectric) or steric field by using molecular mechanics.
 The standard settings (probe with charge +1, radius 1 Å, hydrophobicity +1, hydrogen-
bond donating +1, hydrogen-bond acceptor +1, attenuation factor a 0.3, and grid spacing
2.0 Å) were used to calculate five fields viz.
 Steric,
 Electrostatic,
 Hydrophobic,
 Acceptor,
 Donor.
 Similarity indices Afk, a probe atom, systematically placed at the intersections of the lattice,
are calculated according to eq. (e.g At grid point q for molecule j of the data set)
Afk(j) = - ∑ ωprobe, kωik(eiq
-ar)2
 Where i = the summation index over all atoms of the molecule
 ωik = actual value of the physicochemical property k of atom
 ωprobe,k = the probe atom with charge +1
 a= attenuation factor
 eiq = mutual distance between probe atom at grid point q and atom i of the test molecule.
q2 = cross-validation correlation, PRESS = Predicted residual sum of squares; r2 = regression coefficient; SEE = non-cross-
validated standard error of estimate; F = Fisher’s F-value; N = optimal number of Components; r2
bs = obs. r2
SDbs = obseved standard deviation; R2
cv(mean) = mean r2 of cross-validation in 10 groups;
r2
pred(test) = predictive r2;S = steric, E = electrostatic, H= hydrophobic field.
Hip-Hop algorithm-based alignment MCS-based alignment
COMSIA COMSIA
Statistical parameters CoMFA (TS) SHE SEHA SHA CoMFA (TS) SHE SEHA SHA
q2
0.573 0.723 0.656 0.634 0.568 0.258 0.236 0.241
PRESS 0.404 0.319 0.361 0.373 0.405 0.513 0.523 0.511
r2 0.972 0.950 0.948 0.957 0.954 0.583 0.475 0.445
SEE 0.103 0.135 0.141 0.127 0.131 0.385 0.425 0.437
F 202.624 143.520 105.151 130.470 121.411 14.428 14.487 12.819
N 5 4 5 5 5 3 2 2
fraction S 0.585 0.196 0.162 0.517 0.517 0.189 0.156 0.219
E 0.415 0.476 0.332 0.483 0.483 0.359 0.265 -
H - 0.328 0.257 - - 0.452 0.301 0.411
A - - 0.247 - - - 0.277 0.370
r2
bs 0.987 0.960 0.963 0.971 0.975 0.696 0.571 0.479
SDbs 0.006 0.012 0.014 0.014 0.016 0.072 0.111 0.074
r2cv(mean) 0.566 0.700 0.621 0.584 0.546 0.245 0.227 0.160
r2
pred(test) 0.614 0.690 0.720 0.788 0.497 0.381 0.296 0.375
Graph show observed versus predicted AChE inhibitory activities (pIC50; nM) of both training set and test set
compounds using the best CoMFA (TS) model & CoMSIA (SHA) model.
CoMFA and CoMSIA Model and its Predictive Power
(A) CoMFA (TS) (B) CoMSIA (SHA)
The favorable hydrophobic areas are indicated by a yellow color, whereas the disfavored
hydrophobic areas are shown by a white color.
The favorable steric areas are shown in green, and the disfavored steric areas are shown in
yellow.
The positive potential favored areas are shown in blue, and the positive potential disfavored
areas are shown in red.
CoMSIA Hydrophobic around the most active compound
The hydrophobic favored areas are represented by yellow polyhedra, whereas the hydrophobic disfavored areas are
represented by white polyhedra
 In the present study, an attempt has been made to correlate ache inhibitory activities of the
diverse carbamates with Steric,Electrostatic,Hydrophobic,Donor,Acceptor & field
descriptors.
 The present study, where COMFA and COMSIA models based on pharmacophore-based
alignment are in good agreement with each other and demonstrated significant superiority.
 The CoMFA and CoMSIA steric factor plays an important role as indicated by yellow map
suggesting that more and more bulk, and green map less bulk, respectively, are needed in this
region for enhancement of the activity.
 The validation of the best CoMFA and CoMSIA models based on pharmacophore (hip-hop)-
based alignment on a test set of 17 compounds has provided significant predictive r2
[r2
pred(test)] of 0.614 and 0.788, respectively.
 Hydrophobicity has been found to play a major role in the ache inhibitory activity
modulation.
 The studies suggest that in the development of 3D-QSAR models, the hip-hop-based
alignment may be useful in getting predictive models which may provide useful information
required for proper understanding of the important structural and physicochemical features
for design-ing novel AChE inhibitors.
consensus superiority of the pharmacophore based alignment, over maximum common substructure

Más contenido relacionado

La actualidad más candente

3 d qsar approaches structure
3 d qsar approaches structure3 d qsar approaches structure
3 d qsar approaches structureROHIT PAL
 
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMDENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMShikha Popali
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screeningJoon Jyoti Sahariah
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARRaniBhagat1
 
Docking based screening of drugs.
Docking based screening of drugs.Docking based screening of drugs.
Docking based screening of drugs.Himanshu Yadav
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)suhaspatil114
 
Traditional and Rational Drug Designing
Traditional and Rational Drug DesigningTraditional and Rational Drug Designing
Traditional and Rational Drug DesigningManish Kumar
 
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)AkshayYadav176
 
Rational drug design method
Rational drug design methodRational drug design method
Rational drug design methodRangnathChikane
 
Target discovery and validation
Target discovery and validation Target discovery and validation
Target discovery and validation ANAND SAGAR TIWARI
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisKomalJAIN122
 
COMPUTER AIDED DRUG DESIGN
COMPUTER AIDED DRUG DESIGNCOMPUTER AIDED DRUG DESIGN
COMPUTER AIDED DRUG DESIGNRaniBhagat1
 
RATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptx
RATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptxRATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptx
RATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptxsakshinalkande
 
Hansch and free wilson analysis
Hansch and free wilson analysisHansch and free wilson analysis
Hansch and free wilson analysisDrARIFA1
 

La actualidad más candente (20)

3 d qsar approaches structure
3 d qsar approaches structure3 d qsar approaches structure
3 d qsar approaches structure
 
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARMDENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
DENOVO DRUG DESIGN AS PER PCI SYLLABUS M.PHARM
 
Structure based in silico virtual screening
Structure based in silico virtual screeningStructure based in silico virtual screening
Structure based in silico virtual screening
 
De novo drug design
De novo drug designDe novo drug design
De novo drug design
 
STATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSARSTATISTICAL METHOD OF QSAR
STATISTICAL METHOD OF QSAR
 
Rationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration ofRationale of prodrug design and practical consideration of
Rationale of prodrug design and practical consideration of
 
Docking based screening of drugs.
Docking based screening of drugs.Docking based screening of drugs.
Docking based screening of drugs.
 
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
LEAD IDENTIFICATION BY SUHAS PATIL (S.K.)
 
Traditional and Rational Drug Designing
Traditional and Rational Drug DesigningTraditional and Rational Drug Designing
Traditional and Rational Drug Designing
 
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
Pharmacophore Mapping and Virtual Screening (Computer aided Drug design)
 
Rational drug design method
Rational drug design methodRational drug design method
Rational drug design method
 
Target discovery and validation
Target discovery and validation Target discovery and validation
Target discovery and validation
 
SAR & QSAR
SAR & QSARSAR & QSAR
SAR & QSAR
 
Qsar
QsarQsar
Qsar
 
Relationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysisRelationship between hansch analysis and free wilson analysis
Relationship between hansch analysis and free wilson analysis
 
COMPUTER AIDED DRUG DESIGN
COMPUTER AIDED DRUG DESIGNCOMPUTER AIDED DRUG DESIGN
COMPUTER AIDED DRUG DESIGN
 
3D QSAR
3D QSAR3D QSAR
3D QSAR
 
pharmacophore mapping
pharmacophore mapping pharmacophore mapping
pharmacophore mapping
 
RATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptx
RATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptxRATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptx
RATIONAL AND TRADITIONAL DRUG DESIGN Drug Discovery.pptx
 
Hansch and free wilson analysis
Hansch and free wilson analysisHansch and free wilson analysis
Hansch and free wilson analysis
 

Destacado

Pharmacohoreppt
PharmacohorepptPharmacohoreppt
PharmacohorepptAbhik Seal
 
Pharmacophore mapping in Drug Development
Pharmacophore mapping in Drug DevelopmentPharmacophore mapping in Drug Development
Pharmacophore mapping in Drug DevelopmentMbachu Chinedu
 
Pharmacophore mapping
Pharmacophore mappingPharmacophore mapping
Pharmacophore mapping12nima34
 
Pharmacophore model
Pharmacophore modelPharmacophore model
Pharmacophore modelnatapple
 
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...Prasanthperceptron
 
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Pavan Kumar
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and developmentFarzana Sultana
 
Pharmaceutical chemistry
Pharmaceutical chemistryPharmaceutical chemistry
Pharmaceutical chemistryRupal Agarwal
 
Pharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningPharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningVinod Tonde
 

Destacado (14)

Pharmacohoreppt
PharmacohorepptPharmacohoreppt
Pharmacohoreppt
 
Pharmacophore mapping in Drug Development
Pharmacophore mapping in Drug DevelopmentPharmacophore mapping in Drug Development
Pharmacophore mapping in Drug Development
 
Pharmacophore mapping
Pharmacophore mappingPharmacophore mapping
Pharmacophore mapping
 
project presentation
project presentationproject presentation
project presentation
 
Pharmacophore model
Pharmacophore modelPharmacophore model
Pharmacophore model
 
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
Pharmacophore based ligand-designing_using_substructure_searching_to_explore_...
 
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
Exploration of a potential FtsZ inhibitors as new scaffolds by Ligand and Str...
 
Cook2010web
Cook2010webCook2010web
Cook2010web
 
Drug design, discovery and development
Drug design, discovery and developmentDrug design, discovery and development
Drug design, discovery and development
 
22.pharmacophore
22.pharmacophore22.pharmacophore
22.pharmacophore
 
Denovo Drug Design
Denovo Drug DesignDenovo Drug Design
Denovo Drug Design
 
Pharmaceutical chemistry
Pharmaceutical chemistryPharmaceutical chemistry
Pharmaceutical chemistry
 
Pharmacophore identification
Pharmacophore identificationPharmacophore identification
Pharmacophore identification
 
Pharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug DesigningPharmacophore Modeling in Drug Designing
Pharmacophore Modeling in Drug Designing
 

Similar a consensus superiority of the pharmacophore based alignment, over maximum common substructure

Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Atai Rabby
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseJayashankar Lakshmanan
 
PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...
PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...
PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...Simone Brogi
 
IJBB-51-3-188-200
IJBB-51-3-188-200IJBB-51-3-188-200
IJBB-51-3-188-200sankar basu
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipRaniBhagat1
 
David Minh Brief Stories 2017 Sept
David Minh Brief Stories 2017 SeptDavid Minh Brief Stories 2017 Sept
David Minh Brief Stories 2017 SeptSciCompIIT
 
Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...
Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...
Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...inventionjournals
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design pptAbhik Seal
 
In-silico structure activity relationship study of toxicity endpoints by QSAR...
In-silico structure activity relationship study of toxicity endpoints by QSAR...In-silico structure activity relationship study of toxicity endpoints by QSAR...
In-silico structure activity relationship study of toxicity endpoints by QSAR...Kamel Mansouri
 
Proteome-wide covalent ligand discovery in native biological systems
Proteome-wide covalent ligand discovery in native biological systemsProteome-wide covalent ligand discovery in native biological systems
Proteome-wide covalent ligand discovery in native biological systemsMegha Majumder
 
Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016Shahar Keinan
 
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfDorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfAdinaGeorgiana7
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...KBI Biopharma
 

Similar a consensus superiority of the pharmacophore based alignment, over maximum common substructure (20)

Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)Quantative Structure-Activity Relationships (QSAR)
Quantative Structure-Activity Relationships (QSAR)
 
Insilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastaseInsilico methods for design of novel inhibitors of Human leukocyte elastase
Insilico methods for design of novel inhibitors of Human leukocyte elastase
 
PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...
PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...
PROGRAM PHASE IN LIGAND-BASED PHARMACOPHORE MODEL GENERATION AND 3D DATABASE ...
 
IJBB-51-3-188-200
IJBB-51-3-188-200IJBB-51-3-188-200
IJBB-51-3-188-200
 
Designing an enzyme based nanobiosensor using molecular (2011)
Designing an enzyme based nanobiosensor using molecular (2011)Designing an enzyme based nanobiosensor using molecular (2011)
Designing an enzyme based nanobiosensor using molecular (2011)
 
QSAR by Faizan Deshmukh
QSAR by Faizan DeshmukhQSAR by Faizan Deshmukh
QSAR by Faizan Deshmukh
 
RBC Poster Final
RBC Poster FinalRBC Poster Final
RBC Poster Final
 
Quantitative Structure Activity Relationship
Quantitative Structure Activity RelationshipQuantitative Structure Activity Relationship
Quantitative Structure Activity Relationship
 
David Minh Brief Stories 2017 Sept
David Minh Brief Stories 2017 SeptDavid Minh Brief Stories 2017 Sept
David Minh Brief Stories 2017 Sept
 
Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...
Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...
Antibacterial Activity of Schiff Bases Derived from OrthoDiaminocyclohexane, ...
 
Qsar and drug design ppt
Qsar and drug design pptQsar and drug design ppt
Qsar and drug design ppt
 
POSTER 2013.ppt
POSTER 2013.pptPOSTER 2013.ppt
POSTER 2013.ppt
 
In-silico structure activity relationship study of toxicity endpoints by QSAR...
In-silico structure activity relationship study of toxicity endpoints by QSAR...In-silico structure activity relationship study of toxicity endpoints by QSAR...
In-silico structure activity relationship study of toxicity endpoints by QSAR...
 
Proteome-wide covalent ligand discovery in native biological systems
Proteome-wide covalent ligand discovery in native biological systemsProteome-wide covalent ligand discovery in native biological systems
Proteome-wide covalent ligand discovery in native biological systems
 
Qsar by hansch analysis
Qsar by hansch analysisQsar by hansch analysis
Qsar by hansch analysis
 
Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016Cloud Pharmaceuticals white paper.LIE_2016
Cloud Pharmaceuticals white paper.LIE_2016
 
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdfDorobantu Adina BMS2 - Molecular Biology FLR.pdf
Dorobantu Adina BMS2 - Molecular Biology FLR.pdf
 
E0362430
E0362430E0362430
E0362430
 
Event 32
Event 32Event 32
Event 32
 
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
Size-Exclusion Chromatography with On-Line Light-Scattering, Absorbance, and ...
 

Más de Deepak Rohilla

Más de Deepak Rohilla (11)

drug like property concepts in pharmaceutical design
drug like property concepts in pharmaceutical designdrug like property concepts in pharmaceutical design
drug like property concepts in pharmaceutical design
 
dna Imprinting
 dna Imprinting dna Imprinting
dna Imprinting
 
protein stability
protein stabilityprotein stability
protein stability
 
a b and z dna
a b and z dnaa b and z dna
a b and z dna
 
p53 and cancer
 p53 and cancer p53 and cancer
p53 and cancer
 
Eukaryotic promoters
Eukaryotic promoters Eukaryotic promoters
Eukaryotic promoters
 
Chi sequence
Chi sequenceChi sequence
Chi sequence
 
tata binding protein
tata binding proteintata binding protein
tata binding protein
 
homologus recombination
homologus recombinationhomologus recombination
homologus recombination
 
oncogene as a transcription activator
oncogene as a transcription activatoroncogene as a transcription activator
oncogene as a transcription activator
 
hypnosis
 hypnosis hypnosis
hypnosis
 

Último

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurNavdeep Kaur
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdfDolisha Warbi
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptMumux Mirani
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...saminamagar
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!ibtesaam huma
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptkedirjemalharun
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPrerana Jadhav
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptxMohamed Rizk Khodair
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxdrashraf369
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxDr. Dheeraj Kumar
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Badalona Serveis Assistencials
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?bkling
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxdrashraf369
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfDivya Kanojiya
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptxBibekananda shah
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 

Último (20)

METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaurMETHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
METHODS OF ACQUIRING KNOWLEDGE IN NURSING.pptx by navdeep kaur
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS  CLASSIFICATIONS.pdfLUNG TUMORS AND ITS  CLASSIFICATIONS.pdf
LUNG TUMORS AND ITS CLASSIFICATIONS.pdf
 
SWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.pptSWD (Short wave diathermy)- Physiotherapy.ppt
SWD (Short wave diathermy)- Physiotherapy.ppt
 
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
call girls in Dwarka Sector 21 Metro DELHI 🔝 >༒9540349809 🔝 genuine Escort Se...
 
Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!Biomechanics- Shoulder Joint!!!!!!!!!!!!
Biomechanics- Shoulder Joint!!!!!!!!!!!!
 
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in green park  DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in green park DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Apiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.pptApiculture Chapter 1. Introduction 2.ppt
Apiculture Chapter 1. Introduction 2.ppt
 
Epilepsy
EpilepsyEpilepsy
Epilepsy
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Presentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous SystemPresentation on Parasympathetic Nervous System
Presentation on Parasympathetic Nervous System
 
epilepsy and status epilepticus for undergraduate.pptx
epilepsy and status epilepticus  for undergraduate.pptxepilepsy and status epilepticus  for undergraduate.pptx
epilepsy and status epilepticus for undergraduate.pptx
 
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptxSYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
SYNDESMOTIC INJURY- ANATOMICAL REPAIR.pptx
 
Culture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptxCulture and Health Disorders Social change.pptx
Culture and Health Disorders Social change.pptx
 
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
Presentació "Real-Life VR Integration for Mild Cognitive Impairment Rehabilit...
 
Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?Let's Talk About It: To Disclose or Not to Disclose?
Let's Talk About It: To Disclose or Not to Disclose?
 
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptxPERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
PERFECT BUT PAINFUL TKR -ROLE OF SYNOVECTOMY.pptx
 
Basic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdfBasic principles involved in the traditional systems of medicine PDF.pdf
Basic principles involved in the traditional systems of medicine PDF.pdf
 
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
COVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptxCOVID-19  (NOVEL CORONA  VIRUS DISEASE PANDEMIC ).pptx
COVID-19 (NOVEL CORONA VIRUS DISEASE PANDEMIC ).pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 

consensus superiority of the pharmacophore based alignment, over maximum common substructure

  • 1. 1 Department of Pharmacoinformatics Mohd Rihan PI/309 NIPER HAJIPUR Consensus Superiority of the Pharmacophore-Based Alignment, Over Maximum Common Substructure (MCS): 3D-QSAR Studies on Carbamates as Acetylcholinesterase Inhibitors
  • 2.  Introduction  Biological Data  Rational Division of Trainning and Set Test  Modeling Tools  CoMFA and CoMSIAAnalysis  CoMFA and CoMSIA Predictive Power  Conclusion
  • 3.  Alzheimer’s disease (AD) is A progressive irreversible disorder of elderly patients which is characterized by widespread central cholinergic neuronal loss.  The cholinesterase (ChE) inhibitors are being used to for the symptomatic treatment of the ad affected persons.  The AChE inhibitors are beneficial in improving cognitive and behavioral symptoms, but their effectiveness has been questioned because they do not delay or prevent the neurodegeneration.  Newer approaches viz.  Multitarget directed ligands (MTDLS) .  Beta-amyloid targeted therapies(BATT).  Two types of ChE enzyme  Acetylcholinesterase  Butyrylcholinesterase
  • 4.  Computer aided drug design (CADD) techniques most commonly used techniques:  Indirect/ligand based drug design (LBDD) .  Direct/structure-based drug design (SBDD).  Most commonly used conformer-based alignments, namely,  Cocrystallized conformer-based alignment (CCBA).  Docked conformer-based alignment (DCBA).  Global minima energy conformer-based alignment (GMCBA).  Complete X-ray structure of carbamates cocrystallized with AChE enzyme is not available.  Cocrystallized rivastigmine as well as ganstigmine are in broken form with carbamate part being covalently bound with the OH functionality of the Ser200 amino acid residue.  3D-QSAR model development using  Comparative molecular field analysis (COMFA)  Comparative molecular similarity indices analysis (COMSIA).
  • 5.  Biological Data.  3D-QSAR studies were performed on a structurally diverse set of 52 carbamates covering a good range of AChE inhibitory activity.  The pharmacophore modeling using the Hip-Hop algorithm implemented in the CATALYST software carried out on 12 set of molecules with low to high activity.  The AChE inhibitory activity of the compounds, expressed in the IC50 value in the nanomolar (nM) range, was transformed into -logIC50 (pIC50).
  • 6.  Several methods for the classification of the data set into training and test sets viz.  Random sampling (RS),  Activity ranked clustering (ARC)  Descriptor based clustering (DBC  Therefore, the data set comprising 52 compounds was divided into  Training (35 compounds)  Test (17 compounds) sets)
  • 7.  The pharmacophore modeling was accomplished using the Hip-Hop module implemented in CATALYST.  The 3D-QSAR studies were done on a (CoMFA and CoMSIA) Silicon Graphics Octane workstation using SYBYL 6.9 software.31. Methodology.  The steps used in the development of the 3D-QSAR model using the two strategies viz.  Hip-Hop algorithm based Alignment  MCS-based Alignment
  • 8.
  • 9. Maximum Common Substructure (MCS) of 52 AChE inhibitors
  • 10. Hip-Hop algorithm-based conformational alignment of 52 AChE inhibitors with the important regions assigned namely as Regions 1, 2, and 3.
  • 11. (A) Common feature-based (Catalyst/Hip-Hop) pharmacophore model (Hypo1) with distance angular Å. (B) mapping of the most active molecule [Hydrophobic (blue), hydrogen bond acceptor (green), ring aromatic (yellow), and positive ionizable (red) and the distance between chemical features are shown in Å].
  • 12.  Chemical features selection as input, CATALYST produces a series of possible molecular alignments.  CATALYST identify common features without considering biological activity.  CATALYST produced possible molecular alignment and identify 3D configuration features which is common in set of molecules.  The hypotheses are ranked based on  The number of molecules fitting the pharmacophore.  The frequency of its occurrence (rank score).
  • 13.
  • 14. * An idicates the test set compounds. An #indicates compounds used for pharmacophore design using the CATALYST/Hip-Hop module.
  • 15.  CoMFA provided quantitative correlation of particular activity of molecules with parameters in terms  Steric  Electrostatic field.  In CoMFA analysis lignad paced in a 3D lattice and then steric and electrostatic field of lattice can calculated.  Resulting field of ligand is analysed by Patial Least Square (PLS).  Procedure can be summarized into three steps:  First, all molecules under study are aligned using a molecular alignment methods Viz. common-substructure based, and pharmacophore-based, etc.  3D cubic lattice with a grid spacing of 2.0 Å in x, y, and z directions are generated to enclose the molecule aggregate.  A probe atom, is placed at every lattice point to measure the electrostatic (Columbic with 1/r dielectric) or steric field by using molecular mechanics.
  • 16.  The standard settings (probe with charge +1, radius 1 Å, hydrophobicity +1, hydrogen- bond donating +1, hydrogen-bond acceptor +1, attenuation factor a 0.3, and grid spacing 2.0 Å) were used to calculate five fields viz.  Steric,  Electrostatic,  Hydrophobic,  Acceptor,  Donor.  Similarity indices Afk, a probe atom, systematically placed at the intersections of the lattice, are calculated according to eq. (e.g At grid point q for molecule j of the data set) Afk(j) = - ∑ ωprobe, kωik(eiq -ar)2  Where i = the summation index over all atoms of the molecule  ωik = actual value of the physicochemical property k of atom  ωprobe,k = the probe atom with charge +1  a= attenuation factor  eiq = mutual distance between probe atom at grid point q and atom i of the test molecule.
  • 17. q2 = cross-validation correlation, PRESS = Predicted residual sum of squares; r2 = regression coefficient; SEE = non-cross- validated standard error of estimate; F = Fisher’s F-value; N = optimal number of Components; r2 bs = obs. r2 SDbs = obseved standard deviation; R2 cv(mean) = mean r2 of cross-validation in 10 groups; r2 pred(test) = predictive r2;S = steric, E = electrostatic, H= hydrophobic field. Hip-Hop algorithm-based alignment MCS-based alignment COMSIA COMSIA Statistical parameters CoMFA (TS) SHE SEHA SHA CoMFA (TS) SHE SEHA SHA q2 0.573 0.723 0.656 0.634 0.568 0.258 0.236 0.241 PRESS 0.404 0.319 0.361 0.373 0.405 0.513 0.523 0.511 r2 0.972 0.950 0.948 0.957 0.954 0.583 0.475 0.445 SEE 0.103 0.135 0.141 0.127 0.131 0.385 0.425 0.437 F 202.624 143.520 105.151 130.470 121.411 14.428 14.487 12.819 N 5 4 5 5 5 3 2 2 fraction S 0.585 0.196 0.162 0.517 0.517 0.189 0.156 0.219 E 0.415 0.476 0.332 0.483 0.483 0.359 0.265 - H - 0.328 0.257 - - 0.452 0.301 0.411 A - - 0.247 - - - 0.277 0.370 r2 bs 0.987 0.960 0.963 0.971 0.975 0.696 0.571 0.479 SDbs 0.006 0.012 0.014 0.014 0.016 0.072 0.111 0.074 r2cv(mean) 0.566 0.700 0.621 0.584 0.546 0.245 0.227 0.160 r2 pred(test) 0.614 0.690 0.720 0.788 0.497 0.381 0.296 0.375
  • 18. Graph show observed versus predicted AChE inhibitory activities (pIC50; nM) of both training set and test set compounds using the best CoMFA (TS) model & CoMSIA (SHA) model. CoMFA and CoMSIA Model and its Predictive Power
  • 19. (A) CoMFA (TS) (B) CoMSIA (SHA) The favorable hydrophobic areas are indicated by a yellow color, whereas the disfavored hydrophobic areas are shown by a white color. The favorable steric areas are shown in green, and the disfavored steric areas are shown in yellow. The positive potential favored areas are shown in blue, and the positive potential disfavored areas are shown in red.
  • 20. CoMSIA Hydrophobic around the most active compound The hydrophobic favored areas are represented by yellow polyhedra, whereas the hydrophobic disfavored areas are represented by white polyhedra
  • 21.  In the present study, an attempt has been made to correlate ache inhibitory activities of the diverse carbamates with Steric,Electrostatic,Hydrophobic,Donor,Acceptor & field descriptors.  The present study, where COMFA and COMSIA models based on pharmacophore-based alignment are in good agreement with each other and demonstrated significant superiority.  The CoMFA and CoMSIA steric factor plays an important role as indicated by yellow map suggesting that more and more bulk, and green map less bulk, respectively, are needed in this region for enhancement of the activity.  The validation of the best CoMFA and CoMSIA models based on pharmacophore (hip-hop)- based alignment on a test set of 17 compounds has provided significant predictive r2 [r2 pred(test)] of 0.614 and 0.788, respectively.  Hydrophobicity has been found to play a major role in the ache inhibitory activity modulation.  The studies suggest that in the development of 3D-QSAR models, the hip-hop-based alignment may be useful in getting predictive models which may provide useful information required for proper understanding of the important structural and physicochemical features for design-ing novel AChE inhibitors.